Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Pieris Pharmaceuticals Total Long Term Liabilities 1970-1969 | PVLA

Pieris Pharmaceuticals total long term liabilities from 1970 to 1969. Total long term liabilities can be defined as the sum of all non-current liabilities.
  
Pieris Pharmaceuticals Annual Total Long Term Liabilities
(Millions of US $)
Pieris Pharmaceuticals Quarterly Total Long Term Liabilities
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.016B $0.043B
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Swiftmerge Acquisition (ANNA) United States $0.042B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00